NASDAQ: AGIO       Agios Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
45.908   -0.052 (0.11%)  44.79 - 48.29  313,149


Avg Volume (4 weeks):746,711
4 Weeks Range:41.15 - 48.40
4 Weeks Price Volatility (%):
52 Weeks Range:27.774 - 56.745
52 Weeks Price Volatility (%):
Average Price Target: 132.00
Price Target Upside/Downside: +86.092


No recent Headlines for this stock.

Business Background

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1991  4335  322  3253 

Top 10 Active Counters
 NAKD 0.51+0.074 
 F 11.832+0.972 
 LK 1.38+1.38 
 ACST 0.91+0.154 
 BBIG 6.269+4.729 
 CLSN 1.86+0.585 
 WPX 9.43+0.48 
 CTRM 0.345+0.02 
 SNDL 0.656-0.025 
 ADTX 4.04+1.43